145 related articles for article (PubMed ID: 18061306)
1. Spontaneous osteoclastogenesis is a predictive factor for bone metastases from non-small cell lung cancer.
Roato I; Gorassini E; Buffoni L; Lyberis P; Ruffini E; Bonello L; Baldi I; Ciuffreda L; Mussa A; Ferracini R
Lung Cancer; 2008 Jul; 61(1):109-16. PubMed ID: 18061306
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement.
Roato I; Grano M; Brunetti G; Colucci S; Mussa A; Bertetto O; Ferracini R
FASEB J; 2005 Feb; 19(2):228-30. PubMed ID: 15550550
[TBL] [Abstract][Full Text] [Related]
3. IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor.
Roato I; Brunetti G; Gorassini E; Grano M; Colucci S; Bonello L; Buffoni L; Manfredi R; Ruffini E; Ottaviani D; Ciuffreda L; Mussa A; Ferracini R
PLoS One; 2006 Dec; 1(1):e124. PubMed ID: 17205128
[TBL] [Abstract][Full Text] [Related]
4. Bone resorption activity of osteolytic metastatic lung and breast cancers.
Shih LY; Shih HN; Chen TH
J Orthop Res; 2004 Nov; 22(6):1161-7. PubMed ID: 15475192
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
6. Osteoclasts are active in bone forming metastases of prostate cancer patients.
Roato I; D'Amelio P; Gorassini E; Grimaldi A; Bonello L; Fiori C; Delsedime L; Tizzani A; De Libero A; Isaia G; Ferracini R
PLoS One; 2008; 3(11):e3627. PubMed ID: 18978943
[TBL] [Abstract][Full Text] [Related]
7. Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis.
Colucci S; Brunetti G; Cantatore FP; Oranger A; Mori G; Quarta L; Cirulli N; Mancini L; Corrado A; Grassi FR; Grano M
J Pathol; 2007 May; 212(1):47-55. PubMed ID: 17370327
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity in transthoracic fine-needle biopsy aspirates from non-small cell lung cancer as prognostic factor of patients' survival.
Targowski T; Jahnz-Rózyk K; Szkoda T; Płusa T; From S
Lung Cancer; 2008 Jul; 61(1):97-103. PubMed ID: 18063440
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy.
Sekine I; Nokihara H; Yamamoto N; Kunitoh H; Ohe Y; Tamura T
Lung Cancer; 2009 Aug; 65(2):219-22. PubMed ID: 19081161
[TBL] [Abstract][Full Text] [Related]
10. Increased Dickkopf-1 expression in breast cancer bone metastases.
Voorzanger-Rousselot N; Goehrig D; Journe F; Doriath V; Body JJ; Clézardin P; Garnero P
Br J Cancer; 2007 Oct; 97(7):964-70. PubMed ID: 17876334
[TBL] [Abstract][Full Text] [Related]
11. Detection of MAGE-A transcripts in bone marrow is an independent prognostic factor in operable non-small-cell lung cancer.
Sienel W; Mecklenburg I; Dango S; Ehrhardt P; Kirschbaum A; Passlick B; Pantel K
Clin Cancer Res; 2007 Jul; 13(13):3840-7. PubMed ID: 17606715
[TBL] [Abstract][Full Text] [Related]
12. Bone metastases in gastric cancer follow a RANKL-independent mechanism.
D'Amico L; Satolli MA; Mecca C; Castiglione A; Ceccarelli M; D'Amelio P; Garino M; De Giuli M; Sandrucci S; Ferracini R; Roato I
Oncol Rep; 2013 Apr; 29(4):1453-8. PubMed ID: 23404437
[TBL] [Abstract][Full Text] [Related]
13. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
14. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients.
Leeming DJ; Koizumi M; Byrjalsen I; Li B; Qvist P; Tankó LB
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):32-8. PubMed ID: 16434583
[TBL] [Abstract][Full Text] [Related]
15. The clinical significance of serum markers of bone turnover in NSCLC patients: surveillance, management and prognostic implications.
Terpos E; Kiagia M; Karapanagiotou EM; Charpidou A; Dilana KD; Nasothimiou E; Harrington KJ; Polyzos A; Syrigos KN
Anticancer Res; 2009 May; 29(5):1651-7. PubMed ID: 19443381
[TBL] [Abstract][Full Text] [Related]
16. IL-7 modulates osteoclastogenesis in patients affected by solid tumors.
Roato I; Gorassini E; Brunetti G; Grano M; Ciuffreda L; Mussa A; Ferracini R
Ann N Y Acad Sci; 2007 Nov; 1117():377-84. PubMed ID: 17584976
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related protein measured at the time of first visit is an indicator of bone metastases and survival in lung carcinoma patients with hypercalcemia.
Hiraki A; Ueoka H; Bessho A; Segawa Y; Takigawa N; Kiura K; Eguchi K; Yoneda T; Tanimoto M; Harada M
Cancer; 2002 Oct; 95(8):1706-13. PubMed ID: 12365018
[TBL] [Abstract][Full Text] [Related]
18. A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
Motohashi S; Nagato K; Kunii N; Yamamoto H; Yamasaki K; Okita K; Hanaoka H; Shimizu N; Suzuki M; Yoshino I; Taniguchi M; Fujisawa T; Nakayama T
J Immunol; 2009 Feb; 182(4):2492-501. PubMed ID: 19201905
[TBL] [Abstract][Full Text] [Related]
19. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
